Literature DB >> 22215693

Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage.

Daniel P Fitzgerald1, Preeti Subramanian, Monika Deshpande, Christian Graves, Ira Gordon, Yongzhen Qian, Yeva Snitkovsky, David J Liewehr, Seth M Steinberg, José D Paltán-Ortiz, Mary M Herman, Kevin Camphausen, Diane Palmieri, S Patricia Becerra, Patricia S Steeg.   

Abstract

Brain metastases are a significant cause of morbidity and mortality for patients with cancer, yet preventative and therapeutic options remain an unmet need. The cytokine pigment epithelium-derived factor (PEDF) is downregulated in resected human brain metastases of breast cancer compared with primary breast tumors, suggesting that restoring its expression might limit metastatic spread. Here, we show that outgrowth of large experimental brain metastases from human 231-BR or murine 4T1-BR breast cancer cells was suppressed by PEDF expression, as supported by in vitro analyses as well as direct intracranial implantation. Notably, the suppressive effects of PEDF were not only rapid but independent of the effects of this factor on angiogenesis. Paralleling its cytotoxic effects on breast cancer cells, PEDF also exerted a prosurvival effect on neurons that shielded the brain from tumor-induced damage, as indicated by a relative 3.5-fold reduction in the number of dying neurons adjacent to tumors expressing PEDF. Our findings establish PEDF as both a metastatic suppressor and a neuroprotectant in the brain, highlighting its role as a double agent in limiting brain metastasis and its local consequences. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215693      PMCID: PMC3254209          DOI: 10.1158/0008-5472.CAN-11-1904

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays.

Authors:  Kelli Solly; Xiaobo Wang; Xiao Xu; Berta Strulovici; Wei Zheng
Journal:  Assay Drug Dev Technol       Date:  2004-08       Impact factor: 1.738

2.  Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons.

Authors:  Masako M Bilak; S Patricia Becerra; Andrea M Vincent; Brian H Moss; Maria S Aymerich; Ralph W Kuncl
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

3.  Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.

Authors:  V Stellmach; S E Crawford; W Zhou; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205

4.  Either called "chemobrain" or "chemofog," the long-term chemotherapy-induced cognitive decline in cancer survivors is real.

Authors:  Andreas A Argyriou; Konstantinos Assimakopoulos; Gregoris Iconomou; Fotini Giannakopoulou; Haralabos P Kalofonos
Journal:  J Pain Symptom Manage       Date:  2010-09-15       Impact factor: 3.612

5.  Detecting necrotic neurons with fluoro-jade stain.

Authors:  G J Krinke; W Classen; N Vidotto; E Suter; C H Würmlin
Journal:  Exp Toxicol Pathol       Date:  2001-10

6.  Pigment epithelium-derived factor supports normal development of photoreceptor neurons and opsin expression after retinal pigment epithelium removal.

Authors:  M M Jablonski; J Tombran-Tink; D A Mrazek; A Iannaccone
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

7.  In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor.

Authors:  W Cao; J Tombran-Tink; R Elias; S Sezate; D Mrazek; J F McGinnis
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

8.  Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations.

Authors:  M Cayouette; S B Smith; S P Becerra; C Gravel
Journal:  Neurobiol Dis       Date:  1999-12       Impact factor: 5.996

9.  Fluoro-jade identification of cerebellar granule cell and purkinje cell death in the alpha1A calcium ion channel mutant mouse, leaner.

Authors:  T C Frank; M C Nunley; H D Sons; R Ramon; L C Abbott
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Fluoro-Jade and TUNEL staining as useful tools to identify ischemic brain damage following moderate extradural compression of sensorimotor cortex.

Authors:  Jurgita Kundrotiene; Anna Wägner; Sture Liljequist
Journal:  Acta Neurobiol Exp (Wars)       Date:  2004       Impact factor: 1.579

View more
  25 in total

1.  Analysis of radiation therapy in a model of triple-negative breast cancer brain metastasis.

Authors:  DeeDee Smart; Alejandra Garcia-Glaessner; Diane Palmieri; Sarah J Wong-Goodrich; Tamalee Kramp; Brunilde Gril; Sudhanshu Shukla; Tiffany Lyle; Emily Hua; Heather A Cameron; Kevin Camphausen; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2015-08-30       Impact factor: 5.150

2.  MRI virtual biopsy and treatment of brain metastatic tumors with targeted nanobioconjugates: nanoclinic in the brain.

Authors:  Rameshwar Patil; Alexander V Ljubimov; Pallavi R Gangalum; Hui Ding; Jose Portilla-Arias; Shawn Wagner; Satoshi Inoue; Bindu Konda; Arthur Rekechenetskiy; Alexandra Chesnokova; Janet L Markman; Vladimir A Ljubimov; Debiao Li; Ravi S Prasad; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  ACS Nano       Date:  2015-05-06       Impact factor: 15.881

3.  Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Authors:  Matthew D Dun; Robert J Chalkley; Sam Faulkner; Sheridan Keene; Kelly A Avery-Kiejda; Rodney J Scott; Lasse G Falkenby; Murray J Cairns; Martin R Larsen; Ralph A Bradshaw; Hubert Hondermarck
Journal:  Mol Cell Proteomics       Date:  2015-06-03       Impact factor: 5.911

4.  Temozolomide in secondary prevention of HER2-positive breast cancer brain metastases.

Authors:  Alexandra S Zimmer; Seth M Steinberg; Dee Dee Smart; Mark R Gilbert; Terri S Armstrong; Eric Burton; Nicole Houston; Nadia Biassou; Brunilde Gril; Priscilla K Brastianos; Scott Carter; David Lyden; Stanley Lipkowitz; Patricia S Steeg
Journal:  Future Oncol       Date:  2020-04-09       Impact factor: 3.404

Review 5.  Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.

Authors:  Ulrich H Weidle; Fabian Birzele; Georg Tiefenthaler
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

Review 6.  Emerging strategies for treating brain metastases from breast cancer.

Authors:  David P Kodack; Vasileios Askoxylakis; Gino B Ferraro; Dai Fukumura; Rakesh K Jain
Journal:  Cancer Cell       Date:  2015-02-09       Impact factor: 31.743

7.  Pazopanib inhibits the activation of PDGFRβ-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells.

Authors:  Brunilde Gril; Diane Palmieri; Yongzhen Qian; Talha Anwar; David J Liewehr; Seth M Steinberg; Zoraida Andreu; Daniel Masana; Paloma Fernández; Patricia S Steeg; Fernando Vidal-Vanaclocha
Journal:  Am J Pathol       Date:  2013-04-12       Impact factor: 4.307

Review 8.  The role of the neural niche in brain metastasis.

Authors:  Reid Hoshide; Rahul Jandial
Journal:  Clin Exp Metastasis       Date:  2017-09-13       Impact factor: 5.150

Review 9.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

Review 10.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.